StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
6151.TWO$45.60+5.92%
Fair $45.60+0.0%

6151.TWO

Ginar Technology Co.,Ltd.

Basic Materials / Specialty ChemicalsTaipei Exchange

$45.60

+2.55 (+5.92%)

Fairly Valued+0.0%Fair Value $45.60Fund rank 36/100 · Data gapFallback financials|
SA 62/B
F-Score: 6/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 24% · confianza 25%

FCF escenarios

weak_data · normalized FCF $138.4M · quality 74.0/100

Data gap 36/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 68/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

62/100

B

Piotroski

6/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Sector-specific commodity mid-cycle model required: targets are disabled until normalized cycle price/cost-curve/reserve data exists.
Thesis & Journal · 6151.TWOLocal privado en este navegador · Ginar Technology Co.,Ltd.
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$2.5B

P/E

39.3x

↑

EV/EBITDA

17.4x

↑

ROE

6.5%

↑

Gross Margin

21.5%

↑

Debt/Equity

0.27

↑
52-Week Range$46
$27$51

TradingView lightweight chart

6151.TWO price, volumen y niveles de valoración

Último $45.60Periodo +252.7%
Fair value: $45.60

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+0.4%

FCF CAGR

+2.6%

FCF margin

11.7%

FCF / Net income

3.16x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $1.72B · net income $64.1M · FCF $202.2M

2022-FY → 2025-FY

Gross margin

21.5%+1.3% pts

Operating margin

8.9%+1.5% pts

Net margin

3.7%-2.3% pts

FCF margin

11.7%+0.7% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$1.72B$1.72B$1.66B$1.56B$1.70B
Net Income$64.1M$64.1M$82.0M$85.4M$103.3M
EBITDA$152.7M$152.7M$171.3M$168.1M$191.8M
EPS——1.481.541.86
Gross Margin21.5%21.5%20.0%20.7%20.3%
Operating Margin8.9%8.9%6.9%6.3%7.4%
Net Margin3.7%3.7%4.9%5.5%6.1%
Balance Sheet
Debt/Equity0.270.270.310.390.26
Current Ratio2.092.09———
Cash Flow
Free Cash Flow$202.2M$202.2M$26.1M$138.4M$187.4M
Returns
ROE6.5%6.5%8.0%8.5%9.9%
Valuation
P/E39.3139.3125.2417.4014.38
EV/EBITDA17.4517.4513.4410.278.62
P/B2.552.552.021.481.42
Growth & Yield
Revenue Growth3.4%3.4%6.8%-8.4%—
EPS Growth——-3.9%-17.2%—
Dividend Yield3.8%3.8%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +52.5%

Total return

+52.5%

Start / end P/E

n/dx → n/dx

EPS bridge

1.48 → n/d

Residual

+48.8%

EPS growthn/d
Multiple reratingn/d
Dividend+3.8%
Residual / FX / buybacks / cross-term+48.8%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.